Hospitalist Doctors in Peoria, IL Accepting Medicare

7 Hospitalist doctors found. Showing 1 - 7

Dr. Sheryll Mae Soriano Soriano, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1001 Main St, Suite 200, Peoria, IL 61606 Phone: 309-672-5682    Fax: 309-672-3147

Dr. Venkat Rao Kakollu, M.D Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-3292

Tayyaba Irshad, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-624-8829

Dhaval Save, M.D. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 221 Ne Glen Oak Ave, Peoria, IL 61636 Phone: 312-351-3652

Asra Rab, M.D. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 5409 N Knoxville Ave, Peoria, IL 61614 Phone: 309-691-1000

Dr. Parth Hemantkumar Mehta, M.D. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 221 Ne Glen Oak Ave, Peoria, IL 61636 Phone: 309-672-5729    Fax: 309-672-5772

Deepak Taneja, M.D. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 1001 Main St, Suite 200, Peoria, IL 61606 Phone: 309-672-5682    Fax: 309-672-3147

News Archive

Disability discrimination claims increase

USA Today, in a front page story: "More people with disabilities filed charges of discrimination against their employers last year than at any other time in the 20-year history of the Americans with Disabilities Act. Almost 21,500 ADA-related charges were filed with the Equal Employment Opportunity Commission (EEOC) in 2009.

Enbrel to treat rheumatoid arthritis approved in Japan

Wyeth K.K. and Takeda Pharmaceutical Company Limited (Takeda) have announced that Enbrel (etanercept) has been approved by the Japan Ministry of Health, Labour and Welfare (MHLW) for the treatment of rheumatoid arthritis (RA) in patients who had an inadequate response to existing therapies.

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the "RNA Silencing: Mechanism, Biology, and Application" Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam's therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington's disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.

Bill Protzmann to present on the healing power of music to The 60 Minute University

Bill Protzmann brings his presentation on the healing power of music to The 60 Minute University in Indian Wells on Monday December 14th, 2009 from 9-10am, at the Miramonte Resort & Spa.

Read more Medical News

› Verified 5 days ago